# Biomarkers in Multiple Myeloma

> **NCT05259553** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 70 (estimated)

## Conditions studied

- Hematological Patients
- Newly Diagnosed Multiple Myeloma
- Chemotherapy

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT05259553
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-20
- **Primary completion:** 2025-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259553, "Biomarkers in Multiple Myeloma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05259553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
